Ongoing Clinical Trials for Arterial Stiffness
There is currently one clinical trial recruiting participants to study treatments for arterial stiffness. This trial is investigating whether colchicine, an anti-inflammatory medication, can help reduce the stiffness of arteries in patients with high blood pressure, which is an important factor in preventing cardiovascular complications.
Clinical trial locations
- Denmark
Study on the Effects of Colchicine on Arterial Stiffness in Patients with High Blood Pressure
This clinical trial is investigating how colchicine affects arterial stiffness in people with high blood pressure. When arteries become stiff, the heart has to work harder to pump blood through the body, which can lead to serious cardiovascular problems. The study aims to determine whether colchicine, a medication traditionally used to reduce inflammation, can help improve the flexibility and health of arteries.
Main inclusion criteria:
- Participants must be adults over 18 years old living in the Capital Region of Denmark
- Must have been diagnosed with hypertension and be taking at least one blood pressure-lowering medication
- Must meet at least one additional high-risk criterion: having type 2 diabetes, taking medication for unhealthy fat levels in the blood, or taking two or more blood pressure medications
- Women of childbearing potential must use effective birth control during the study and for 30 days after
- Must provide written informed consent and be willing to follow the study requirements
Main exclusion criteria:
- Having a history of cardiovascular disease
- Being outside the specified age range for the study
- Being part of a vulnerable population that might need special protection or care
What happens during the trial:
The study lasts for six months. Participants will be randomly assigned to receive either colchicine tablets or a placebo, which looks identical but contains no active medication. Throughout the trial, researchers will monitor arterial stiffness using a technique called pulse wave velocity analysis, which measures how fast blood pressure waves move through the arteries. They will also track blood pressure readings and other heart health indicators.
At the beginning of the study, baseline measurements are taken to establish starting points for comparison. Participants then take their assigned medication orally as tablets. Regular monitoring visits allow researchers to track changes in arterial stiffness, blood pressure, and other health markers. Some participants may undergo additional tests such as echocardiography to assess heart function. At the end of the six-month period, final measurements are taken and compared to the initial assessment to evaluate whether colchicine had an effect on arterial health.
Investigational drug:
The medication being studied is colchicine, specifically Colchicin “Tiofarma” tablets. Colchicine works at the molecular level by disrupting structures inside cells called microtubules, which can reduce inflammation. Researchers believe this anti-inflammatory effect might help improve the flexibility of blood vessels and reduce arterial stiffness in people with high blood pressure.
Summary
Currently, there is one active clinical trial exploring new approaches to managing arterial stiffness. This condition is an important factor in cardiovascular health, as stiff arteries force the heart to work harder and can lead to complications over time. The trial is taking place in Denmark and focuses on whether colchicine, an anti-inflammatory medication, can help improve arterial flexibility in patients with high blood pressure who are at high risk for cardiovascular problems.
The study represents an innovative approach to cardiovascular health by investigating whether reducing inflammation might help improve the physical properties of blood vessels. This could potentially offer a new treatment option for people with hypertension who need additional help managing their condition beyond standard blood pressure medications.
